6505--LENALIDOMIDE Jesse Brown VA Medical Center

The contract pertains to the procurement of Lenalidomide (Revlimid) medication for the Jesse Brown VA Medical Center in Chicago, Illinois, under solicitation number 36C25226Q0112. Issued by the VA Great Lakes Acquisition Center and managed through the 252-NETWORK Contract Office 12 in Milwaukee, Wisconsin, the procurement follows FAR Part 13 simplified acquisition procedures, emphasizing a firm-fixed price arrangement. The solicitation, posted on November 21, 2025, with an extended deadline for offers now set for December 3, 2025, requires offerors to submit an itemized quotation along with technical documentation to demonstrate compliance with product specifications and regulatory standards. The basis for award is expected to be the lowest price that meets all technical and compliance requirements, adhering to the Lowest Price Technically Acceptable (LPTA) approach. The RFQ emphasizes the importance of detailed submissions via email to the designated contracting specialist, Arneil Genus, and references the need for offerors to provide sufficient technical support to verify product compliance. While specific clauses, inspection criteria, packaging standards, and detailed line-item data are not explicitly provided in the available documentation, the solicitation indicates compliance with applicable FAR clauses and standards under NAICS code 325412, which pertains to pharmaceutical manufacturing. The contract's scope is limited to supplying the pharmaceutical product, with performance expected at the VA facility, and the procurement process includes provisions for amendments, such as a recent extension of the offer due date. Overall, the contract aims to secure a compliant, cost-effective supply of Lenalidomide for veteran care, with clear instructions for submission and evaluation criteria centered on price and technical acceptability.